AwardedHealthcare & Medical🇨🇿Czech Republic
Immunosuppressive Drugs Supply Contract
This public procurement contract involves the ongoing supply of immunosuppressive medications containing risankizumab, tofacitinib, apremilast, mirikizumab, deucravacitinib, voclosporin, and siltuximab over a period of 4 years, based on the current needs of the contracting authority. The total value
€52,829,572FACULTY HOSPITAL HRADEC KRLOV Published 26 Jun 2025